Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
74.01
+0.06 (0.08%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Hologic Revenue
Hologic had revenue of $1.02B in the quarter ending June 28, 2025, with 1.23% growth. This brings the company's revenue in the last twelve months to $4.04B, up 1.29% year-over-year. In the fiscal year ending September 28, 2024, Hologic had annual revenue of $4.03B.
Revenue (ttm)
$4.04B
Revenue Growth
+1.29%
P/S Ratio
4.19
Revenue / Employee
$571,839
Employees
7,063
Market Cap
16.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 28, 2024 | 4.03B | -100.00K | - |
| Sep 30, 2023 | 4.03B | -832.40M | -17.12% |
| Sep 24, 2022 | 4.86B | -769.50M | -13.66% |
| Sep 25, 2021 | 5.63B | 1.86B | 49.14% |
| Sep 26, 2020 | 3.78B | 409.10M | 12.15% |
| Sep 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 24, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 26, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
HOLX News
- 6 days ago - Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX - Business Wire
- 7 days ago - Blackstone, TPG to Buy Hologic for Up to $18.3 Billion - WSJ
- 8 days ago - Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal - Reuters
- 8 days ago - Hologic to be Acquired by Blackstone and TPG for up to $79 per Share - Business Wire
- 9 days ago - Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks - Barrons
- 26 days ago - Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025 - Business Wire
- 27 days ago - Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis - Business Wire
- 4 weeks ago - New Survey Results Underscore the Need to #BustTheMyth About Mammograms - Business Wire